Records containing: Prurigo Nodularis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-06-02A Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of Stapokibart Injection in Subjects With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2026-04-23Phase 1a/1b Randomized Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single- and Multiple-Ascending Doses and Food Effect of BGB-45035 in Healthy Participants and Its Safety and Tolerability in Patients With Autoimmune Dermatological Diseases
-
CLINICAL_TRIALS study record update · 2026-04-14A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2026-04-13A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2026-03-12Real-world Experience on Using Nemolizumab in the Treatment of Moderate-to- Severe Prurigo Nodularis in Adults
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-01-30A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab (CDX-0159) in Patients With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2026-01-20A Phase 3, 52-Week, Multicenter, Randomized, Placebo-controlled, Double-blind Study to Assess the Efficacy, Safety, and Tolerability of Rocatinlimab in Adult Subjects With Prurigo Nodularis Who Are Inadequately Controlled on Topical Therapies or Not Eligible for Topical Therapies
-
CLINICAL_TRIALS study record update · 2026-01-15A Multicenter Open-label Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2026-01-13A Phase 2a/b, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy, Safety, Tolerability and Pharmacokinetics of KPL-716 in Reducing Pruritus in Subjects With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2025-11-24A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2025-11-21The Effect of the EMD Protocol for Urge Compared to Care as Usual on Dermatology-specific Quality of Life
-
CLINICAL_TRIALS study record update · 2025-11-12A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2025-09-16A Prospective Observational Study of Patients Receiving Dupilumab for Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2025-08-13A Maximal Use Trial of Ruxolitinib Cream in Adult Participants With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2025-08-13Prospective, Non-interventional Observational Study to Characterize Dupilumab Long-term Treatment, Safety and Patient Reported Outcomes in Chronic Nodular Prurigo (Prurigo Nodularis) in Clinical Routine
-
CLINICAL_TRIALS study record update · 2025-07-22Determinants of Chronic Inflammatory Skin Disease Trajectories
-
CLINICAL_TRIALS study record update · 2025-06-24A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 2-Arm, Efficacy and Safety Study in Prurigo Nodularis (PN) With Nalbuphine ER Tablets for Pruritus Relief Through Itch Scratch Modulation (PRISM Study)
-
CLINICAL_TRIALS study record update · 2025-05-29Efficacy of Topical Cannabidiol in Patients With Eczema
-
CLINICAL_TRIALS study record update · 2025-05-22A Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of Stapokibart Injection in Subjects With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2025-04-18A Randomized, Double-blind, Placebo-controlled Phase III Study Evaluating the Efficacy and Safety of a Humanized MG-K10 Mab Injection in Subjects With Prurigo Nodularis.
-
CLINICAL_TRIALS study record update · 2025-01-15A 24 Week, Open-Label Study to Evaluate the Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2024-10-10A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II/III Clinical Study of the Efficacy and Safety of SHR-1819 Injection in Adult Patients With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2024-10-08A Double-Blind, Placebo-Controlled, Randomized Study to Assess the Durability of Effect and Safety of Nemolizumab for 24 Weeks in Subjects With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2024-08-27A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Ranging Study of the Efficacy and Safety of INCB054707 in Participants With Prurigo Nodularis
-
CLINICAL_TRIALS study record update · 2024-08-15China Type II Inflammatory Skin Disease Clinical Research and Standardized Diagnosis and Treatment Project: a National Multicenter Prospective Cohort Study